Ano1/TMEM16A Overexpression Is Associated with Good Prognosis in PR-Positive or HER2-Negative Breast Cancer Patients following Tamoxifen Treatment

Huizhe Wu; Shu Guan; Mingli Sun; Zhaojin Yu; Lin Zhao; Miao He; Haishan Zhao; Weifan Yao; Enhua Wang; Feng Jin; Qinghuan Xiao; Minjie Wei

doi:10.1371/journal.pone.0126128

Loading metrics

Open Access

Peer-reviewed

Research Article

Ano1/TMEM16A Overexpression Is Associated with Good Prognosis in PR-Positive or HER2-Negative Breast Cancer Patients following Tamoxifen Treatment

Huizhe Wu,

Affiliation Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, Liaoning, P. R. China
⨯
Shu Guan,

Affiliation Department of Breast Surgery, First Hospital of China Medical University, Shenyang, Liaoning, P. R. China
⨯
Mingli Sun,

Affiliation Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, Liaoning, P. R. China
⨯
Zhaojin Yu,

Affiliation Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, Liaoning, P. R. China
⨯
Lin Zhao,

Affiliation Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, Liaoning, P. R. China
⨯
Miao He,

Affiliation Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, Liaoning, P. R. China
⨯
Haishan Zhao,

Affiliation Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, Liaoning, P. R. China
⨯
Weifan Yao,

Affiliation Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, Liaoning, P. R. China
⨯
Enhua Wang,

Affiliation Institute of Pathology and Pathophysiology, First Hospital and College of Basic Medical Sciences of China Medical University, Shenyang, Liaoning, P. R. China
⨯
Feng Jin ,

* E-mail: mjweicmu@hotmail.com (MW); qinghuanxiao@gmail.com (QX); jinfeng66cn@hotmail.com (FJ)

Affiliation Department of Breast Surgery, First Hospital of China Medical University, Shenyang, Liaoning, P. R. China
⨯
Qinghuan Xiao ,

* E-mail: mjweicmu@hotmail.com (MW); qinghuanxiao@gmail.com (QX); jinfeng66cn@hotmail.com (FJ)

Affiliation Department of Ion Channel Pharmacology, School of Pharmacy, China Medical University, Shenyang, Liaoning, P. R. China
⨯
Minjie Wei

* E-mail: mjweicmu@hotmail.com (MW); qinghuanxiao@gmail.com (QX); jinfeng66cn@hotmail.com (FJ)

Affiliation Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, Liaoning, P. R. China
⨯

Ano1/TMEM16A Overexpression Is Associated with Good Prognosis in PR-Positive or HER2-Negative Breast Cancer Patients following Tamoxifen Treatment

Huizhe Wu,
Shu Guan,
Mingli Sun,
Zhaojin Yu,
Lin Zhao,
Miao He,
Haishan Zhao,
Weifan Yao,
Enhua Wang,
Feng Jin

Published: May 11, 2015
https://doi.org/10.1371/journal.pone.0126128

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Prognosis
Is the Subject Area "Prognosis" applicable to this article?

Thanks for your feedback.
Prostate cancer
Is the Subject Area "Prostate cancer" applicable to this article?

Thanks for your feedback.
Head and neck cancers
Is the Subject Area "Head and neck cancers" applicable to this article?

Thanks for your feedback.
Signal amplification
Is the Subject Area "Signal amplification" applicable to this article?

Thanks for your feedback.
Endocrine therapy
Is the Subject Area "Endocrine therapy" applicable to this article?

Thanks for your feedback.
EGFR signaling
Is the Subject Area "EGFR signaling" applicable to this article?

Thanks for your feedback.